Targeting cellular apoptotic pathway with peptides from marine organisms
Lanhong Zheng1, Xiukun Lin, Ning Wu
1Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao, China.
Biochimica Et Biophysica Acta
|March 9, 2013
Summary
Marine peptides offer a promising avenue for cancer therapy by targeting apoptosis (programmed cell death). This review highlights novel marine peptides that activate cancer cell apoptosis, paving the way for new antitumor drugs.
Area of Science:
- Marine biology
- Biochemistry
- Pharmacology
- Cancer research
Background:
- Apoptosis, or programmed cell death, is a vital biological process crucial for preventing cancer development and progression.
- Targeting apoptotic pathways presents a promising strategy for designing novel chemotherapeutic agents.
- Marine organisms are increasingly recognized as a rich source of bioactive compounds with potential antitumor properties.
Purpose of the Study:
- To review marine-derived peptides that modulate apoptotic signaling pathways.
- To highlight novel peptides with demonstrated effects on cancer cell apoptosis.
- To associate these peptides with their pharmacological properties for potential drug development.
Main Methods:
- Literature review of marine peptides and their effects on apoptosis.
- Analysis of studies investigating the mechanisms of action of marine peptides on apoptotic pathways.
- Compilation of information on the pharmacological properties of identified peptides.
Main Results:
- Several marine peptides have been identified that influence apoptotic signaling pathways in cancer cells.
- Most of these peptides require further in-depth investigation regarding their precise mechanisms of action.
- Novel peptides capable of inducing apoptosis have been presented alongside their pharmacological characteristics.
Conclusions:
- Marine peptides represent a significant resource for the discovery of new anticancer drugs.
- Targeting apoptosis with marine-derived compounds is a viable strategy for cancer chemotherapy.
- Further research into the mechanisms and properties of these peptides is warranted to advance their therapeutic potential.
Related Concept Videos
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...